Guardant Health, Inc. (GH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
119.04-0.40 (-0.33%)
At close: 4:00PM EDT
| Previous close | 119.44 |
| Open | 119.44 |
| Bid | 117.60 x 1000 |
| Ask | 120.37 x 800 |
| Day's range | 117.14 - 120.00 |
| 52-week range | 77.69 - 181.07 |
| Volume | 462,622 |
| Avg. volume | 973,850 |
| Market cap | 12.037B |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.39 |
| Earnings date | 05 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 171.42 |
- Business Wire
Guardant Health to Report Second Quarter Financial Results on August 5, 2021
REDWOOD CITY, Calif., July 13, 2021--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- Simply Wall St.
Did Guardant Health's (NASDAQ:GH) Share Price Deserve to Gain 49%?
Guardant Health, Inc. ( NASDAQ:GH ) shareholders might be concerned after seeing the share price drop 22% in the last...
- Motley Fool
This Explosive Biotech Is Taking On a Huge New Market
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
© 2021 Verizon Media. All rights reserved.
